monoclonal antibody treating autoimmune conditions by targeting interleukin-17A
Ixekizumab is a monoclonal antibody used to treat autoimmune conditions like psoriasis and psoriatic arthritis. It works by targeting and neutralizing interleukin-17A, a protein that plays a key role in inflammatory processes, thereby reducing symptoms and improving skin and joint health.
— no results